-
EP1689737
European procedure
Extract from the Register of European Patents
EP About this file: EP1689737
| EP1689737 - BETA-LACTAMS FOR THE TREATMENT OF CNS DISORDERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.05.2009 Database last updated on 01.04.2026 | Most recent event Tooltip | 22.05.2009 | No opposition filed within time limit | published on 24.06.2009 [2009/26] | Applicant(s) | For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford Middlesex UB6 0NN / GB | [2006/33] | Inventor(s) | 01 /
ALVARO, Giuseppe, GlaxoSmithKline Via Alessandro Fleming 2 I-37100 Verona / IT | 02 /
DI FABIO, Romano, GlaxoSmithKline Via Alessandro Fleming 2 I-37100 Verona / IT | 03 /
GIOVANNINI, Riccardo, GlaxoSmithKline Via Alessandro Fleming 2 I-37100 Verona / IT | 04 /
PAIO, Alfredo, GlaxoSmithKline Via Alessandro Fleming 2 I-37100 Verona / IT | 05 /
TRANQUILLINI, Maria Elvira, GlaxoSmithKline Via Alessandro Fleming 2 I-37100 Verona / IT | 06 /
MATTIOLI, Lucia, GlaxoSmithKline Via Alessandro Fleming 2 I-37100 Verona / IT | [2006/33] | Representative(s) | Giddings, Peter John GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2006/33] | Giddings, Peter John GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 04797809.3 | 10.11.2004 | [2006/33] | WO2004EP12772 | Priority number, date | GB20030026407 | 12.11.2003 Original published format: GB 0326407 | [2006/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005049600 | Date: | 02.06.2005 | Language: | EN | [2005/22] | Type: | A1 Application with search report | No.: | EP1689737 | Date: | 16.08.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.06.2005 takes the place of the publication of the European patent application. | [2006/33] | Type: | B1 Patent specification | No.: | EP1689737 | Date: | 16.07.2008 | Language: | EN | [2008/29] | Search report(s) | International search report - published on: | EP | 02.06.2005 | Classification | IPC: | C07D401/04, A61P25/00, A61K31/4439 | [2006/33] | CPC: |
C07D401/04 (EP,KR,US);
A61P13/10 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/30 (EP);
A61P29/00 (EP);
A61P43/00 (EP);
C07D405/14 (KR)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/33] | Extension states | AL | Not yet paid | HR | 04.05.2006 | LT | 04.05.2006 | LV | 04.05.2006 | MK | Not yet paid | YU | Not yet paid | Title | German: | BETA-LACTAME ZUR BEHANDLUNG VON ERKRANKUNGEN DES ZNS | [2006/33] | English: | BETA-LACTAMS FOR THE TREATMENT OF CNS DISORDERS | [2006/33] | French: | BETA-LACTAMES POUR LE TRAITEMENT DE TROUBLES DU SYSTEME NERVEUX CENTRAL | [2006/33] | Entry into regional phase | 04.05.2006 | National basic fee paid | 04.05.2006 | Designation fee(s) paid | 04.05.2006 | Examination fee paid | Examination procedure | 04.05.2006 | Examination requested [2006/42] | 30.11.2007 | Communication of intention to grant the patent | 31.03.2008 | Fee for grant paid | 31.03.2008 | Fee for publishing/printing paid | Opposition(s) | 17.04.2009 | No opposition filed within time limit [2009/26] | Fees paid | Renewal fee | 06.11.2006 | Renewal fee patent year 03 | 06.11.2007 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||